Raymond James Financial Services Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,236
| Closed | -$585K | – | 3504 |
|
|
2024
Q2 | $585K | Sell |
14,236
-1,407
| -9% | -$57.8K | ﹤0.01% | 2415 |
|
|
2024
Q1 | $730K | Sell |
15,643
-3,935
| -20% | -$184K | ﹤0.01% | 2253 |
|
|
2023
Q4 | $936K | Sell |
19,578
-2,530
| -11% | -$121K | ﹤0.01% | 2014 |
|
|
2023
Q3 | $788K | Buy |
22,108
+12,403
| +128% | +$442K | ﹤0.01% | 2042 |
|
|
2023
Q2 | $448K | Buy |
+9,705
| New | +$448K | ﹤0.01% | 2402 |
|
|
2019
Q2 | – | Sell |
-2,929
| Closed | -$203K | – | 2861 |
|
|
2019
Q1 | $203K | Buy |
+2,929
| New | +$203K | ﹤0.01% | 2492 |
|
|
2016
Q4 | – | Sell |
-8,350
| Closed | -$592K | – | 2374 |
|
|
2016
Q3 | $592K | Buy |
+8,350
| New | +$592K | 0.01% | 1405 |
|